Statements of Operations (Parenthetical) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Revenues	$ 20,729	$ 122,112
Cost of revenue	52,595	375,845
Research and development expenses	8,413,923	7,317,388
Related Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Revenues		33,388
Cost of revenue		118,497
Research and development expenses	$ 1,418,887	$ 368,372